Actively Recruiting

Age: 20Years - 80Years
All Genders
Healthy Volunteers
ID06047028

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

Led by University of Texas Southwestern Medical Center · Updated on 2026-02-27

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Texas Southwestern Medical Center

Lead Sponsor

A

American Heart Association

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating the use of Hyperpolarized 13C MRI, a noninvasive imaging technique, to evaluate heart metabolism in people with heart failure due to coronary artery disease. This study aims to improve how patients are selected for coronary artery bypass surgery by measuring the bicarbonate-to-lactate ratio in the heart muscle. The research compares these measurements before and after surgery with values from healthy volunteers to better understand heart metabolism in these groups. Participants include healthy volunteers aged 20 to 80 years with no history of coronary artery disease or diabetes, and patients scheduled for coronary artery bypass surgery who have one or more blocked coronary vessels. The study involves MRI scans at baseline for healthy subjects, preoperative imaging for surgery patients, and follow-up imaging 4 to 6 months after surgery. The research also examines the safety and reproducibility of the Hyperpolarized 13C pyruvate used during the MRI. During the study, participants will undergo MRI exams to measure the bicarbonate-to-lactate ratio, alongside blood tests to assess related metabolic markers like pyruvate and insulin. Echocardiograms will assess heart wall motion to explore links between metabolism and heart function. The study tracks changes over time, focusing on heart metabolism before and after surgery, with safety and tolerability monitored throughout. The total participation period can extend from initial imaging to months following surgery.

CONDITIONS

Brief Title

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

Who Can Participate

Age: 20Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 20 and 80 years
  • Male or female participants
  • Preoperative patients with left ventricular ejection fraction (LVEF) less than 0.35
  • Healthy subjects with LVEF greater than 0.50
  • Patients scheduled for coronary artery bypass surgery with one or more stenotic coronary vessels
  • Blood pressure below 140/90 mm Hg
  • Heart rate around 78 beats per minute
  • Hypertension allowed
  • Current smokers allowed but will be reported
  • Medication use within 24 hours will be recorded
Not Eligible

You will not qualify if you...

  • History of myocardial infarction excluded for healthy subjects
  • Diabetes mellitus excluded for all participants
  • Coronary artery bypass surgery history excluded for healthy subjects
  • Infarct type and location excluded for healthy subjects
  • Number of diseased coronary vessels excluded for healthy subjects
  • Other medical histories or clinical data varying by physician practices may exclude participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants undergo noninvasive hyperpolarized 13C MRI to assess myocardial metabolism and related blood measurements.

1 visit (in-person)

Long-term Monitoring

Duration - 4 to 6 months

Participants who have undergone coronary artery bypass surgery are followed up 4 to 6 months postoperatively for repeated MRI evaluation and assessment of myocardial metabolism changes.

1 follow-up visit (in-person)

Trial Site Locations

Total: 1 location

1

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Actively Recruiting

Loading map...

Research Team

S

Sarah S McNeil

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Elut...

Elevated Lipoprotein(a) Level

Actively Recruiting

1 location

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

AMJ-401 Japan Clinical Trial for Ischemic Heart Disease Eval...

Ischemic Heart Disease (IHD)

Actively Recruiting

10 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here